Sell GlaxoSmithKline Consumer, tgt Rs 587: IIFL

3913 Investors following GlaxoSmith Con. Share this News with them.

0

Like this story, share it with millions of investors on M3

Sell GlaxoSmithKline Consumer, tgt Rs 587: IIFL

IIFL has initiated a sell rating on GlaxoSmithKline Consumer Healthcare with a 12-month target price of Rs 587. The stock is trading at a one-year-forward PE of 14.3x, in line with its five-year PE average.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Buy Madras Cement, tgt Rs 4000: Sharekhan ONGC an underperformer: Enam Buy Tata Chemical, tgt Rs 391: Karvy Buy NIIT, target of Rs 132: Emkay Buy United Phosphorous, target of Rs 330: IIFL GlaxoSmith Con BSE | NSE 25/05/12 Are Mutual Funds betting on GlaxoSmith Con?

IIFL has initiated a sell rating on GlaxoSmithKline Consumer Healthcare with a 12-month target price of Rs 587 in its July 2, 2008 research report. "GSK Consumer is the market leader in the malted-beverages category, with brands such as Horlicks, Boost, Maltova and Viva. We expect a significant deceleration in the company's earnings growth as EBITDA margin drops on high raw-material cost and rising ad expenses on new product launches."

"The stock is trading at a one-year-forward PE of 14.3x, in line with its five-year PE average. Initiate with a SELL and a 12-month target price of Rs 587, based on a target PE of 12x on one-year forward earnings," says IIFL's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

For further details click on attachment.......